Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date18 Nov 2019 |
100 Clinical Results associated with Guiyang Dechangxiang Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guiyang Dechangxiang Pharmaceutical Co., Ltd.
100 Deals associated with Guiyang Dechangxiang Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guiyang Dechangxiang Pharmaceutical Co., Ltd.